Literature DB >> 626068

Cardiovascular impairment and physical working capacity in children with chronic renal failure.

H E Ulmer, H Griener, H W Schüler, K Schärer.   

Abstract

Forty children with chronic renal failure (CRF) on conservative treatment, on hemodialysis, or after renal transplantation and 22 children respresenting a non-uremic control group were subjected to repeated cardiologic examinations by ECG, PCG, chest X-rays and cycle ergometer exercise tests to monitor signs of uremic heart disease and to evaluate physical working capacity (W170). In the CRF group a progressive impairment of W170 was found, starting at an early stage of the disease. Exercise tolerance was inversely related to the degree of CRF. A correlation was also found between W170 and renal anemia. After starting dialysis, W170 failed to increase significantly. Immediately after dialysis an acute drop in W170 occurred. Renal anemia was found to be the main pathogenetic factor of uremic heart disease in children. In some cases hypercirculation following arteriovenous fistulae became equally important as a cause of reduced myocardial performance. Physical rehabilitation, as measured by exercise tolerance tests, was better in transplanted than in dialysed children.

Entities:  

Mesh:

Year:  1978        PMID: 626068     DOI: 10.1111/j.1651-2227.1978.tb16275.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  8 in total

Review 1.  Cardiovascular complications in pediatric end-stage renal disease.

Authors:  Rulan S Parekh; Samuel S Gidding
Journal:  Pediatr Nephrol       Date:  2004-12-15       Impact factor: 3.714

2.  Erythrocyte organic phosphates in the anemia of renal failure in childhood.

Authors:  D E Müller-Wiefel; K Schärer; W Fischer; D Michalk
Journal:  Eur J Pediatr       Date:  1978-06-20       Impact factor: 3.183

3.  Recombinant human erythropoietin therapy in children maintained by haemodialysis.

Authors:  S P Rigden; G Montini; M Morris; K G Clark; G B Haycock; C Chantler; R C Hill
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Exercise tolerance after anaemia correction with recombinant human erythropoietin in end-stage renal disease.

Authors:  E Baraldi; G Montini; S Zanconato; G Zacchello; F Zacchello
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

5.  Spiroergometric performance of children and adolescents with chronic renal failure.

Authors:  K E Bonzel; B Wildi; M Weiss; K Schärer
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

6.  Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis.

Authors:  B A Warady; R J Sabath; C A Smith; U Alon; S Hellerstein
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

Review 7.  [Reno-cardiac interactions in kidney failure (author's transl)].

Authors:  P Kramer; M Schmidt-Lauber; N Langenheim; W Zwehl; G Sold; H Luig; D Matthaei; H J Gröne; H V Henning; F Scheler
Journal:  Klin Wochenschr       Date:  1980-10-01

8.  Pulmonary function and exercise tolerance are related to disease severity in pre-dialytic patients with chronic kidney disease: a cross-sectional study.

Authors:  Ruiter de Souza Faria; Natália Fernandes; Júlio César Moraes Lovisi; Maycon de Moura Reboredo; Murilo Sérgio de Moura Marta; Bruno do Valle Pinheiro; Marcus Gomes Bastos
Journal:  BMC Nephrol       Date:  2013-09-04       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.